Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC)
Chauvergne, J., Fumoleau, P., Cappelaere, P., Metz, R., Armand, J.P., Chevallier, B., Kerbrat, P., de Forni, M., Lhommé, C., Roche, H., Chollet, Ph., Goupil, A., Guiochet, N., Herait, P., Lentz, M.A.Volume:
29
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/0959-8049(93)90384-R
Date:
January, 1993
File:
PDF, 683 KB
english, 1993